Metsera the US obesity biotech at centre of Novo, Pfizer bidding war

Core Insights - Metsera has emerged as a leading player in the obesity drug market, attracting significant attention and investment [1] Company Summary - Metsera is positioned as a key competitor in the obesity treatment sector, indicating strong market potential and interest from investors [1] Industry Summary - The obesity drug market is experiencing heightened activity, with Metsera being recognized as a pivotal entity within this growing industry [1]